UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)
CUSIP: M96088105
Q3 2017 13F Holders as of 30 Sep 2017
- Type / Class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Shares outstanding
- 46,986,408
- Total 13F shares
- 3,121,706
- Share change
- -144,275
- Total reported value
- $98,400,000
- Price per share
- $31.52
- Number of holders
- 29
- Value change
- +$1,688,330
- Number of buys
- 18
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP M96088105?
CUSIP M96088105 identifies URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP M96088105:
Top shareholders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ProQuest Associates IV LLC |
13F
|
Company |
3.1%
|
1,451,329
|
$26,211,000 | — | 30 Jun 2017 | |
| FMR LLC |
13F
|
Company |
1.6%
|
769,230
|
$13,892,000 | — | 30 Jun 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.6%
|
752,740
|
$13,596,000 | — | 30 Jun 2017 | |
| HIGHLINE CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.91%
|
425,300
|
$7,681,000 | — | 30 Jun 2017 | |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. |
13F
|
Company |
0.75%
|
352,300
|
$6,363,000 | — | 30 Jun 2017 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.57%
|
269,014
|
$4,858,000 | — | 30 Jun 2017 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.37%
|
175,410
|
$3,168,000 | — | 30 Jun 2017 | |
| Wildcat Capital Management, LLC |
13F
|
Company |
0.29%
|
135,000
|
$2,439,000 | — | 30 Jun 2017 | |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
|
Company |
0.27%
|
129,055
|
$2,331,000 | — | 30 Jun 2017 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.11%
|
50,000
|
$903,000 | — | 30 Jun 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0.1%
|
47,400
|
$856,000 | — | 30 Jun 2017 | |
| Coastal Bridge Advisors, LLC |
13F
|
Company |
0.08%
|
38,461
|
$695,000 | — | 30 Jun 2017 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.07%
|
32,908
|
$594,000 | — | 30 Jun 2017 | |
| NORGES BANK |
13F
|
Company |
0.06%
|
29,900
|
$540,000 | — | 30 Jun 2017 | |
| Parkwood LLC |
13F
|
Company |
0.06%
|
27,694
|
$500,000 | — | 30 Jun 2017 | |
| J.P. Morgan Private Wealth Advisors LLC |
13F
|
Company |
0.03%
|
12,250
|
$221,000 | — | 30 Jun 2017 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.02%
|
10,806
|
$195,000 | — | 30 Jun 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
7,560
|
$136,000 | — | 30 Jun 2017 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
380
|
$7,000 | — | 30 Jun 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
373
|
$7,000 | — | 30 Jun 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
279
|
$5,000 | — | 30 Jun 2017 |
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q3 2017
As of 30 Sep 2017,
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,121,706 shares.
The largest 10 holders included
FMR LLC, MENORA MIVTACHIM HOLDINGS LTD., HIGHLINE CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, JENNISON ASSOCIATES LLC, Wildcat Capital Management, LLC, CREDIT SUISSE AG/, DSAM Partners (London) Ltd, and BAINCO INTERNATIONAL INVESTORS.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
21
Q3 2017 holders
29
Holder diff
8
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.